Overview

Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
This is a phase II study where chemotherapy (gemcitabine) is given into the urinary bladder.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Gemcitabine